银华国证港股通创新药ETF(159567)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
57,563,784.18 |
4,135,422.61 |
872,662.59 |
| 存出保证金 |
184,229.08 |
- |
1,924.10 |
| 交易性金融资产 |
2,615,386,427.15 |
367,400,164.63 |
129,070,001.76 |
| 其中：股票投资 |
2,615,386,427.15 |
367,400,164.63 |
129,070,001.76 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
1,069.48 |
| 应收利息 |
- |
- |
- |
| 应收股利 |
3,397,756.14 |
- |
420,564.80 |
| 应收申购款 |
- |
- |
- |
| 其他资产 |
- |
- |
96,167.05 |
| 资产总计 |
2,961,899,493.60 |
384,173,512.28 |
136,020,860.24 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
232,798,808.97 |
6,039,268.58 |
1,041,692.81 |
| 应付赎回款 |
- |
- |
- |
| 应付管理人报酬 |
848,889.91 |
161,468.89 |
57,377.47 |
| 应付托管费 |
169,778.01 |
32,293.76 |
11,475.49 |
| 应付销售服务费 |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
703,658.85 |
138,589.47 |
52,942.93 |
| 负债合计 |
234,521,135.74 |
6,371,620.70 |
1,163,488.70 |
| 所有者权益 |
| 实收基金 |
1,806,364,863.00 |
395,364,863.00 |
171,364,863.00 |
| 未分配利润 |
921,013,494.86 |
-17,562,971.42 |
-36,507,491.46 |
| 所有者权益合计 |
2,727,378,357.86 |
377,801,891.58 |
134,857,371.54 |
| 负债及所有者权益总计 |
2,961,899,493.60 |
384,173,512.28 |
136,020,860.24 |
微信公众号
证券之星APP
基本资料
